Variation in Cannabis Testing Challenges a Young Industry

The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.

Written byKatarina Zimmer
| 14 min read

Register for free to listen to this article
Listen with Speechify
0:00
14:00
Share

ABOVE: An employee at California-based testing company CannaSafe preps a cannabis sample for testing. © CANNASAFE

When voters in Massachusetts approved a 2012 ballot measure to legalize the sale and use of medical marijuana, it came as a relief for many patients: they now had legal access to a drug known to relieve chronic pain and muscle spasticity associat-ed with a range of conditions, including HIV and multiple sclerosis. But the new law worried Christopher Hudalla, then a chemist at Waters Corporation, a Massachusetts-based company that manufactures analytical laboratory instruments. Like other states, Massachusetts had legalized cannabis without mandating that the herb, or products derived from it, be tested for safety before being sold, which struck Hudalla as odd.

Why would marijuana, especially as it’s being considered medical—why would that not be tested?

“Anything we put on or in our body is tested, whether it’s cosmetics, or lotions, or bread, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile

Published In

March 2020

Rising Seas, Dead Trees

Ghost forests are a warning about climate change

Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies